These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Hoppe B; Groothoff JW; Hulton SA; Cochat P; Niaudet P; Kemper MJ; Deschênes G; Unwin R; Milliner D Nephrol Dial Transplant; 2011 Nov; 26(11):3609-15. PubMed ID: 21460356 [TBL] [Abstract][Full Text] [Related]
14. Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degrading enzyme in mice with hyperoxaluria. Grujic D; Salido EC; Shenoy BC; Langman CB; McGrath ME; Patel RJ; Rashid A; Mandapati S; Jung CW; Margolin AL Am J Nephrol; 2009; 29(2):86-93. PubMed ID: 18698135 [TBL] [Abstract][Full Text] [Related]
15. Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria. Takei K; Ito H; Masai M; Kotake T Urol Int; 1998; 61(3):192-5. PubMed ID: 9933846 [TBL] [Abstract][Full Text] [Related]
16. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Campieri C; Campieri M; Bertuzzi V; Swennen E; Matteuzzi D; Stefoni S; Pirovano F; Centi C; Ulisse S; Famularo G; De Simone C Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105 [TBL] [Abstract][Full Text] [Related]
17. Recombinant Lactobacillus plantarum expressing and secreting heterologous oxalate decarboxylase prevents renal calcium oxalate stone deposition in experimental rats. Sasikumar P; Gomathi S; Anbazhagan K; Abhishek A; Paul E; Vasudevan V; Sasikumar S; Selvam GS J Biomed Sci; 2014 Aug; 21(1):86. PubMed ID: 25175550 [TBL] [Abstract][Full Text] [Related]
18. Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease? Peck AB; Canales BK; Nguyen CQ Urolithiasis; 2016 Feb; 44(1):45-50. PubMed ID: 26645869 [TBL] [Abstract][Full Text] [Related]
19. Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation. Mikami K; Akakura K; Takei K; Ueda T; Mizoguchi K; Noda M; Miyake M; Ito H Int J Urol; 2003 Jun; 10(6):293-6. PubMed ID: 12757596 [TBL] [Abstract][Full Text] [Related]
20. Use of a probiotic to decrease enteric hyperoxaluria. Lieske JC; Goldfarb DS; De Simone C; Regnier C Kidney Int; 2005 Sep; 68(3):1244-9. PubMed ID: 16105057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]